• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Neuroinflammation . Nociceptor neurons shape antiviral immunity

tetano

Editor, Senior Moderator
J Neuroinflammation


. 2026 Apr 21;23(1):137.
doi: 10.1186/s12974-026-03817-z.
Nociceptor neurons shape antiviral immunity

Isaac Thomas[SUP] 1 [/SUP], Anais Roger[SUP] 1 [/SUP], Moutih Rafei[SUP] 2 [/SUP], Katrina Gee[SUP] 1 [/SUP], Sebastien Talbot[SUP] 3 4 [/SUP], Sam Basta[SUP] 5 [/SUP]


Affiliations
Abstract

The nervous and immune systems cooperate to protect the host, yet the contribution of sensory neurons to antiviral immunity remains incompletely defined. Nociceptor neurons do more than relay pain: they detect viral products and inflammatory cues through pattern-recognition receptors (PRRs), including Toll-like receptors (TLRs) and RIG-I-like receptors (RLRs), and respond to mediators such as type I interferons (IFNs), tumor necrosis factor (TNF), and interleukin-1β (IL-1β). Upon activation, these fibres release neuropeptides and neurotransmitters, including calcitonin gene-related peptide (CGRP) and substance P (SP), while sympathetic catecholamines provide a parallel neural input that shapes vascular tone, leukocyte trafficking, and effector programmes across tissues. Viral infection can also engage neuro-glial circuits in sensory ganglia and, in some settings, spread directly to the central nervous system (CNS), as described for lymphocytic choriomeningitis virus (LCMV), herpes simplex virus (HSV), and selected influenza A virus (IAV) strains. Here, we synthesize evidence that nociceptors shape antiviral immunity in a context-dependent manner rather than exerting uniform control. Nav1.8⁺ afferents restrain excessive inflammation while supporting dendritic cell (DC) priming of CD8⁺ T cells during cutaneous HSV-1 infection; vagal TRPV1⁺ neurons, a subset of Nav1.8⁺ nociceptors, promote disease tolerance during influenza by tuning lung myeloid responses; CGRP signaling drives T helper (Th) 1 differentiation during acute LCMV infection; and sympathetic adrenergic inputs deepen CD8⁺ T cell exhaustion during chronic infection. Defining these neuro-immune circuits may reveal therapeutic opportunities, but species differences, circuit heterogeneity, and the pleiotropic effects of shared mediators will need to be resolved before these insights can be translated to human disease.

Keywords: Adaptive immunity; Antiviral immunity; Herpes Simplex Virus (HSV); Infection; Inflammation; Influenza A Virus (IAV); Innate immunity; Lymphocytic Choriomeningitis Virus (LCMV); Neuro-immunology; Nociceptor neurons.

 
Back
Top